EUVIMEDEUVIMED entdecken
Crossref

QbD-Optimized Resveratrol-Loaded NLCs with Bioactive Lipids for Enhanced Topical Therapy of Psoriasis

Bjad K. Almutairy, Abdullah Alshetaili, Mohammed Aldawsari, Munerah Alfadhel, Aftab Alam, Mohd Imran

Journal of Pharmaceutical Innovation · 2026-06 · 21 (3)

DOI: 10.1007/s12247-026-10438-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical Innovation, online erschienen am 03.03.2026. Verfasst von Bjad K. Almutairy und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Prince Sattam bin Abdulaziz University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Prince Sattam bin Abdulaziz University

Zitieren

APA

Almutairy, B. K., Alshetaili, A., Aldawsari, M., Alfadhel, M., Alam, A., & Imran, M. (2026). QbD-Optimized Resveratrol-Loaded NLCs with Bioactive Lipids for Enhanced Topical Therapy of Psoriasis. Journal of Pharmaceutical Innovation, 21(3). https://doi.org/10.1007/s12247-026-10438-9

Vancouver

Almutairy BK, Alshetaili A, Aldawsari M, Alfadhel M, Alam A, Imran M. QbD-Optimized Resveratrol-Loaded NLCs with Bioactive Lipids for Enhanced Topical Therapy of Psoriasis. Journal of Pharmaceutical Innovation. 2026;21(3). doi:10.1007/s12247-026-10438-9

BibTeX
@article{Almutairy2026,
  author = {Almutairy, Bjad K. and Alshetaili, Abdullah and Aldawsari, Mohammed and Alfadhel, Munerah and Alam, Aftab and Imran, Mohd},
  title = {QbD-Optimized Resveratrol-Loaded NLCs with Bioactive Lipids for Enhanced Topical Therapy of Psoriasis},
  journal = {Journal of Pharmaceutical Innovation},
  year = {2026},
  volume = {21},
  number = {3},
  doi = {10.1007/s12247-026-10438-9}
}
Kostenlos starten →